We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.8B
AUM Growth
+$401M
Cap. Flow
-$819M
Cap. Flow %
-3.94%
Top 10 Hldgs %
34.88%
Holding
872
New
34
Increased
469
Reduced
316
Closed
42

Sector Composition

Rank Sector Weight
1 Materials 55.1%
2 Energy 8.94%
3 Technology 8.27%
4 Healthcare 6.04%
5 Financials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMAG
251
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
$8.29M 0.04%
385,000
-15,000
-4% -$314K
TJX icon
252
TJX Companies
TJX
$173B
$8.27M 0.04%
156,294
-1,317
-0.8% -$70K
CGBD icon
253
Carlyle Secured Lending
CGBD
$710M
$8.23M 0.04%
540,027
+41,119
+8% +$614K
TEVA icon
254
Teva Pharmaceuticals
TEVA
$36.2B
$8.19M 0.04%
887,757
+352,843
+66% +$4.25M
MFA
255
MFA Financial
MFA
$927M
$8.19M 0.04%
285,219
+32,743
+13% +$956K
IVR icon
256
Invesco Mortgage Capital
IVR
$762M
$8.15M 0.04%
50,548
+3,535
+8% +$569K
NMFC icon
257
New Mountain Finance
NMFC
$649M
$8.12M 0.04%
581,452
+13,080
+2% +$183K
CVS icon
258
CVS Health
CVS
$137B
$8.11M 0.04%
148,905
-1,209
-0.8% -$65.1K
ARI
259
Apollo Commercial Real Estate
ARI
$876M
$8M 0.04%
434,853
+23,595
+6% +$439K
WTRU
260
DELISTED
Essential Utilities, Inc.6.00% Tangible Equity Units
WTRU
$7.86M 0.04%
+138,001
New +$7.67M
ENB icon
261
Enbridge
ENB
$121B
$7.8M 0.04%
216,429
+23,641
+12% +$861K
TAK icon
262
Takeda Pharmaceutical
TAK
$55.7B
$7.78M 0.04%
439,339
+30,751
+8% +$560K
BTT icon
263
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
$7.75M 0.04%
333,572
+41,560
+14% +$943K
WBA
264
DELISTED
Walgreens Boots Alliance
WBA
$7.65M 0.04%
139,990
+6,301
+5% +$335K
DTV
265
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
$7.59M 0.04%
135,001
-5,193
-4% -$290K
ALNY icon
266
Alnylam Pharmaceuticals
ALNY
$37.2B
$7.58M 0.04%
104,449
-20,824
-17% -$1.6M
WELL icon
267
Welltower
WELL
$175B
$7.5M 0.04%
92,036
+1,891
+2% +$149K
LAC
268
DELISTED
Lithium Americas Corp. Common Shares
LAC
$7.47M 0.04%
1,853,084
+748,999
+68% +$2.97M
LADR
269
Ladder Capital
LADR
$1.24B
$7.46M 0.04%
449,325
+66,527
+17% +$1.11M
NZF icon
270
Nuveen Municipal Credit Income Fund
NZF
$2.41B
$7.45M 0.04%
472,976
-90,076
-16% -$1.4M
SQM icon
271
Sociedad Química y Minera de Chile
SQM
$19.6B
$7.44M 0.04%
239,263
-92,766
-28% -$3.16M
JAZZ icon
272
Jazz Pharmaceuticals
JAZZ
$16B
$7.39M 0.04%
51,861
-251
-0.5% -$33.7K
GBDC icon
273
Golub Capital BDC
GBDC
$3.36B
$7.28M 0.04%
417,699
-88,220
-17% -$1.55M
ICL icon
274
ICL Group
ICL
$6.65B
$7.27M 0.04%
1,398,504
-443,736
-24% -$2.35M
XOM icon
275
ExxonMobil
XOM
$642B
$7.19M 0.03%
93,796
+8,022
+9% +$621K

Similar funds

VanEck Associates's Q2 2019 Portfolio in Review

As of Q2 2019, VanEck Associates held 872 positions worth $20.8B, up 2% from $20.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

VanEck Associates withdrew a net $819M in Q2 2019, closing 42 positions and reducing 316 holdings. Its most notable exit was Goldcorp Inc, an estimated $586M position sold in full.

By sector, the portfolio is most concentrated in Materials at 55% of assets, down from 56% a quarter earlier, followed by Energy and Technology.

Against the trend, VanEck Associates opened a new position in Royal Dutch Shell PLC ADS Class B worth $38.4M.

  • VanEck Associates's largest Q2 2019 buy was Royal Dutch Shell PLC ADS Class B: 584,700 shares worth $38.4M.
  • VanEck Associates added most to Newmont in Q2 2019, an estimated $311M increase.
  • VanEck Associates's biggest Q2 2019 reduction was Barrick Mining, cutting an estimated $128M.
  • VanEck Associates fully exited Goldcorp Inc in Q2 2019, selling an estimated $586M.
  • VanEck Associates's ten largest holdings make up 35% of its $20.8B portfolio in Q2 2019.
  • VanEck Associates opened 34 new positions and closed 42 in Q2 2019.
  • VanEck Associates's portfolio value rose 2% quarter-over-quarter to $20.8B.

Based on VanEck Associates's 13F filing for Q2 2019, filed 7 Aug 2019.